|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Antibacterial activity of various honey types of Algeria against Pathogenic Gram–Negative Bacilli: Escherichia coli and Pseudomonas aeruginosa显示文摘 | Ahmed Moussa Djebli Noureddine Meslem Abdelmelek Aissat Saad | 2012 | Asian Pacific Journal of Tropical Disease2012，，3： | 5 |
| 2 | Additive potential of ginger starch on antifungal potency of honey against Candida albicans显示文摘Objective:To evaluate the additive action of ginger starch on the antifungal activity of honey against Candida albicans(C.albicans).Methods:C.albicans was used to determine the minimum inhibitory concentration(MIC)of four varieties of Algerian honey.Lower concentrations of honey than the MIC were incubated with a set of concentrations of starch and then added to media to detennine the minimum additive inhibitory concentration(MAIC).Results:The MIC for the four varieties of honey without starch against C.albicans ranged between 38%and 42%(v/v).When starch was incubated with honey and then added to media,a MIC drop was noticed with each variety.MAIC of the four varieties ranged between 32%honey(v/v)with 4%starch and 36%honey(v/v) with 2%starch.Conclusions:The use of ginger starch allows honey benefit and will constitute an alternative way against the resistance to antifungal agents. | Ahmed Moussa Djebli Noureddine Hammoudi SM Aissat Saad Akila Bourabeh Hemida Houari | 2012 | Asian Pacific Journal of Tropical Biomedicine2012，2，4： | 3 |
| 3 | Antifungal activity of four honeys of different types from Algeria against pathogenic yeast:Candida albicans and Rhodotorula sp.显示文摘Objective:To evaluate the antifungal activity of four honeys of different types from Algeria against pathogenic yeast i.e.Candida albicans(C.albicans) and Rhoddtorula sp.Methods:Four Algeria honeys of different botanical origin were analvzed to test anlilungal effect against C.albicans,and Rhodotorula sp.Different concentrations(undiluted,10%,30%,50%and 70%w/v) of honey were studied in vitro for their antifugal aclivity using C.albicans and Rhodotorula sp.as fungal strains.Results:The range of the c liameter of zone of inhibition of various concentrations ol tested honeys was(7-23 mm) for Rhodotorula sp.,while C.albicans showed clearly resistance towards all concentrations used.The MICs of tested honey concentrations against C.albicans and Rhodotorula sp.were(70.09-93.48)%and(4.90-99.70)%v/v,respectively.Conclusions:This study demonstrales that,in vitro,these natural products have clearly an antifungal activity against Rhodotorula sp.and C.albicans. | Ahmed Moussa Djebli Noureddine Aissat Saad Meslem Abdelmelek Benhalima Abdelkader | 2012 | Asian Pacific Journal of Tropical Biomedicine2012，2，7： | 3 |
| 4 | Antibacterial activity of various honey types of Algeria against Staphylococcus aureus and Streptococcus pyogenes显示文摘Objective:To assess the in vitro antibacterial activity of honey from different geographical location on Gram negative organismes.Methods:Different concentrations(Undiluted honey,10%, 30%,50%and 70%wt/vol) of honey were studied in vitro using Staphylococcus aureus(S.aureus) and Streptococcus pyogenes(S.pyogenes),briefly,two-fold dilutions of honey solutions were tested to determine the minimum inhibitory concentration(MIC) against each type of microorganism,followed by more assays within a narrower dilution range to obtain more precise MIC values.MICs were determined by both visual inspection and spectrophotometric assay at 620 nm.These honey samples were compared with standard antibiotics like ampicillin,penicillin G,amoxicillin,gentamycin,tobramycin,erythromycin and chloramphenicol was determined by the disc diffusion method.Results:The diameter of zone of the inhibition(ZDI) of honey has various concentrations tested for the isolates ranged 0-46 mm for S.aureus,0-44 mm for S.pyogenes.While the MIC(%) ranged 12%-95%,25%-73%respectively.Conclusions:Algeria honey,in-vitro,possess antibacterial activity. | Ahmed Moussa Djebli Noureddine Hammoudi Si Mohamed Meslem Abdelmelek Aissat Saad | 2012 | Asian Pacific Journal of Tropical Medicine2012，5，10： | 2 |
| 5 | Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesianmodelling in kidney transplant recipients 显示文摘 | Djebli N Rousseau A Hoizey G | 2006 | Clin Pharmacokinet2006，45，11： | 1 |
| 6 | Arbitraty amplitude ion-acoustic waves in a plasma with nonthermal electrons显示文摘 | Ali-Fedela D Marif H Djebli M | 2010 | Advances in Space Research2010，45，6： | 1 |
| 7 | CYP3A5 * 3 influences sirolimus oral clearance in de novo and stable renal transplant recipients 显示文摘 | Meur YL Djebli N Szelag JC | 2006 | Clin Pharmacol Ther2006，80，1： | 1 |
| 8 | Sirolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian modelling in kidney transplant recipients显示文摘 | Djebli N Rousseau A Hoizey G | 2006 | Clin Pharmacokinet2006，45，11： | 1 |
| 9 | Effect of the chelating agents on bio-sorption of hexavalent chromium using Agave sisalana fibers显示文摘The current work is focused on the study of the bio-sorption of hexavalent chromium from aqueous solution using sisal natural fiber(Agave sisalana) treated by various chelating agents(ligands) such as urea(UR),thiocarbamide(TC), ethylenediaminetetraacetic acid(EDTA), and diphenyl carbazide(DCZ). The fiber treatments were investigated using Fourier Transform Infrared Spectroscopy(FTIR) and Scanning electron microscope(SEM). The kinetics of chromium bio-sorption was studied in batch presses under the effect of some physicochemical factors such as the nature of chelating agent(F@UR, F@TC, F@DCZ, and F@EDTA),adsorbent dose(2–10 g·L^(-1)), chromium initial concentration(100–500 mg·L^(-1)), solution pH(1–6), and batch temperature(20 ℃–50 ℃). This study resulted in an optimum adsorption at a chromium initial concentration of 100 mg·L^(-1), at pH 2, and at 20 ℃. The obtained results showed clearly that the treatment with chelating agent boosts the adsorptive capacity of A. sisalana fibers Cr(VI) 10.9 mg·g^(-1) to 58.6 mg·g^(-1). The modeling study showed that the adsorption kinetics obey the pseudo-second-order model, with an R2 in the range of 0.991 and 0.999. The bio-sorption isotherms followed the Langmuir model; the maximum uptake capacity of(F@N, F@UR,F@TC, F@DCZ, and F@EDTA) was found to be respectively, 12.3 mg·g^(-1), 25.33 mg·g^(-1), 28.73 mg·g^(-1),42.54 mg·g^(-1), and 61.45 mg·g^(-1). The determined adsorption thermodynamics parameters such as enthalpy,free energy, and entropy showed that the adsorption process is exothermic, spontaneous, and has a stable configuration. | H. Bendjeffal A. Djebli H. Mamine T. Metidji M. Dahak N. Rebbani Y. Bouhedja | 2018 | Chinese Journal of Chemical Engineering2018，26，5： | 1 |
| 10 | Antibacterial activity of honey alone and in combination with Nigella sativa seeds against Pseudomonas aeruginosa infection显示文摘 | Meslem Abdelmalek Ahmed Moussa Djebli Noureddine Aissat Saad | 2012 | Asian Pacific Journal of Tropical Disease2012，，： | 1 |
| 11 | A non-linear energy model of fatigue damage accumulation and its verification for Al-2024 aluminum alloy显示文摘 | A. Djebli A. Aid M. Bendouba A. Amrouche M. Benguediab N. Benseddiq | 2013 | International Journal of Non-Linear Mechanics2013，，： | 1 |
| 12 | Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients 显示文摘 | Djebli N Rousseau A Hoizey G | 2006 | Clin Pharmacokinet2006，45，： | 1 |
| 13 | A Non-linear Energy Model of Fatigue Damage Accumulation and Its Verification for A1-2024 Aluminum Alloy 显示文摘 | Djebli A Aid A Bendouba M | 2013 | International Journal of Non-linear Mechan ics2013，51，： | 1 |
| 14 | Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients 显示文摘 | Djebli N Rousseau A Hoizey G | 2006 | Clin Pharmacokinet2006，45，11： | 1 |
| 15 | Sirolimus popula-tion pharmacokinetic/ pharmacogenetic analysis and bayesianmodelling in kidney transplant recipients 显示文摘 | DJEBLI N ROUSSEAU A HOIZEY G | 2006 | Clin Pharmacoki-net2006，45，： | 1 |
| 16 | CYP3A5 * 3 in- fluences sirolimus oral clearance in de novo and stable re- nal transplant recipients 显示文摘 | Meur Y L Djebli N Szelag J C | 2006 | Clin Pharmacol Ther2006，80，1： | 1 |
| 17 | On fast retrieval laws for tethered satellite systems 显示文摘 | DJEBLI A EL BAKKALI L PASCAL M | 2002 | Acta Astronautica2002，50，8： | 1 |
| 18 | CYP3A5 *3 influences sirolimus oral clearance in de novo and stable renal transplant recipients 显示文摘 | LE MEUR Y DJEBLI N SZELAG J C | 2006 | Clin Pharmaeol Ther2006，80，1： | 1 |
| 19 | Sirolimus population pharmaeokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients显示文摘 | Djebli N Rousseau A Hoizey G | 2006 | Clin Pharmacokinet2006，45，11： | 1 |
| 20 | CYP3A5 * 3 influences sirolimus oral clearance in de novo and stable renal transplant recipients显示文摘 | Le Meur Y Djebli N Szelag JC | 2006 | Clin Pharmacol Ther2006，80，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员